Technology ❯ Biotechnology ❯ Nanotechnology

Drug Delivery Systems

Nanoparticles Nano-in-Micro Delivery Nanoparticle Formulations Clinical Efficacy

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline as Securities Case Advances in SDNY

Plaintiffs allege MoonLake overstated sonelokimab’s Nanobody benefits in light of Phase 3 results that failed to show superior efficacy.

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

Nanoparticle 'Super Adjuvant' Vaccine Blocks Multiple Cancers in Mice